Clinical Trials Sponsored by Chengdu Kanghong Biotech Co.,Ltd

Total 751 results

Chengdu Kanghong Biotech Co., Ltd.

Unknown

An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD) (LAMP)

Very Low Vision Secondary to Wet Age-related Macular Degeneration

China
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion (BRAVE)

Macular Edema | Branch Retinal Vein Occlusion

China
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion (CRAVE)

Central Retinal Vein Occlusion | Macular Edema

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy

Gastric Cancer | Gastroesophageal Cancer
Chengdu Kanghong Biotech Co., Ltd.

Unknown

An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization

Corneal Neovascularization

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy

Polypoid Choroidal Vasculopathy (PCV)

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word（STONE）

Wet Age-related Macular Degeneration (wAMD)

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV (SHINY)

Choroid Neovascularization Secondary to Degenerative Myopia

China
Chengdu Kanghong Biotech Co., Ltd.

Terminated

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Neovascular Age-related Macular Degeneration

United States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan
Chengdu Kanghong Biotech Co., Ltd.

Terminated

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)

Neovascular Age-related Macular Degeneration

United States, Bulgaria, China, Czechia, Denmark, France, Hungary, Israel, Italy, Latvia, Slovakia, United Kingdom
Chengdu Kanghong Biotech Co., Ltd.

Unknown

The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) (STAR)

Polypoidal Choroidal Vasculopathy (PCV)

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)

Diabetic Macular Edema

China
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion (FALCON)

Retinal Vein Occlusion

China
Chengdu Kanghong Pharmaceutical Co., Ltd.

Unknown

A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy

Moderately Severe to Severe NPDR
Chengdu Kanghong Biotech Co., Ltd.
Guangzhou Keli Medical Research Co., Ltd.

Enrolling by invitation

Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data

Retinopathy of Prematurity

China
Chengdu Kanghong Biotech Co., Ltd.
University of Wisconsin, Madison

Completed

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD (PHOENIX)

Neovascular Age-related Macular Degeneration

China
Beijing Kanghong Biopharmaceutical Co., Ltd.

Not yet recruiting

Phase 1 Trial of KH801

Advanced Solid Tumors

China
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Recruiting

Phase 1 Study of KH607 Tablets

Healthy

China
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Unknown

Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition

Bioequivalence

China
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

China
Sichuan Jishengtang Pharmaceutical Co., Ltd.

Not yet recruiting

Randomized Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

Generalized Anxiety Disorder
Sichuan Honghe Biotechnology Co., Ltd.

Recruiting

Phase 1 Trial of KH617

Advanced Solid Tumors

China
Chengdu Kanghong Biotech Co., Ltd.
Beijing DMS Pharma Ltd.; The Digital Angiography Reading Center (DARC)

Completed

A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD (AURORA)

Neovascular Age-related Macular Degeneration

China
Chengdu Kanghong Biotech Co., Ltd.
University of Wisconsin, Madison; Air Force Military Medical University, China

Completed

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD (HOPE)

Neovascular Age-related Macular Degeneration

China
Chengdu Kanghong Biotech Co., Ltd.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Recruiting

A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma

Retinoblastoma

China
Taizhou Hanzhong biomedical co. LTD

Recruiting

Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Bladder Cancer

China
Taizhou Hanzhong biomedical co. LTD

Unknown

Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Chengdu Brilliant Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus
Chengdu Suncadia Medicine Co., Ltd.

Not yet recruiting

A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd.

Not yet recruiting

A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism
Chengdu Suncadia Medicine Co., Ltd.

Active, not recruiting

Proof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

China
Chengdu SciMount Pharmatech Co., Ltd.

Completed

A Phase 1 Study of SMP-100 in Normal Healthy Volunteers

Healthy Volunteers

Australia
Chengdu Suncadia Medicine Co., Ltd.

Recruiting

Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria

China
Chengdu Easton Biopharmaceuticals Co,Ltd

Recruiting

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets

Type 2 Diabetes

China
Chengdu SciMount Pharmatech Co., Ltd.

Completed

3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability

Healthy Volunteers

Australia
Chengdu Kanghong Biotech Co., Ltd.
University of Wisconsin, Madison; Teaching and Research Office of Health Statistics...

Completed

Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME) (Frontier-1)

Diabetic Macular Edema

China
Chengdu Brilliant Pharmaceutical Co., Ltd.

Not yet recruiting

The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery

Laparoscopy | Anesthesia, Intravenous

China
Chengdu Suncadia Medicine Co., Ltd.

Recruiting

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Glomerulonephritis

China
Chengdu Easton Biopharmaceuticals Co,Ltd

Recruiting

a Safety and Tolerability Study of EP-9001A in Healthy Volunteers

Healthy Volunteers

China
Chengdu Suncadia Medicine Co., Ltd.

Active, not recruiting

A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)

Chronic Hepatitis B

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

SARS-CoV-2 | COVID-19 Vaccine

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Terminated

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Withdrawn

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

COVID-19

China
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma (NOTABLE-307)

Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Safety and Preliminary Clinical Activity of Itolizumab in ARDS

Acute Respiratory Distress Syndrome
SunWay Biotech Co., LTD.

Recruiting

Effect of Vigiis 101 Lactic Acid Bacteria Powder on Body Weight and Body Fat in Overweight Participants

Overweight | Body Weight | Body Fat

Taiwan

Clinical Trials Sponsored by Chengdu Kanghong Biotech Co.,Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations